Poly-herbal Composition for Broad-Spectrum Efficacy

The patent combines multiple plant extracts (Aloe vera, Azadirachta indica, Citrus sinensis, Zea mays, Origanum vulgare, and other herbs) into a single poly-herbal composition. This merging of multiple botanical sources creates synergistic effects that provide broad-spectrum anticancer, antiviral, and anti-inflammatory properties while maintaining a unified formulation structure that is relatively simple to manufacture and administer.

The invention creates a composite herbal formulation where different plant extracts are combined in specific proportions (each extract at 5-20% v/v) to achieve enhanced therapeutic effects. The composite nature of the formulation allows it to address multiple disease targets simultaneously, providing adaptability across different cancer types and viral infections while maintaining manufacturing simplicity through standardized extraction and mixing processes.

The patent segments the formulation into distinct plant extract components, each contributing specific therapeutic properties. This segmentation allows for standardized extraction and quality control of individual herbs, which can then be combined in predetermined ratios (5-20% v/v each). The segmented approach simplifies manufacturing by enabling modular production of individual extracts before final formulation, reducing overall production complexity despite the multi-component nature of the broad-spectrum formulation.

The invention optimizes the concentration parameters of each plant extract within a specific range (5-20% v/v) to achieve broad-spectrum efficacy while maintaining cost-effectiveness. By establishing standardized concentration parameters for each component, the formulation achieves therapeutic versatility without requiring complex customization during manufacturing. This parameter optimization allows for scalable production with consistent quality across different batches.

The poly-herbal composition is designed with multi-functionality, where each plant extract contributes to multiple therapeutic effects. For example, Aloe vera provides both anticancer and immunomodulatory properties, while Azadirachta indica contributes antiviral and anti-inflammatory effects. This universal approach allows a single formulation to address multiple disease mechanisms simultaneously, enhancing reliability of efficacy without requiring separate formulations for different conditions, thereby reducing overall formulation complexity.

The patent performs preliminary extraction and standardization of each plant component before final formulation. Individual extracts are prepared in advance with controlled concentrations and quality parameters, then combined in the final synergistic composition. This preliminary action ensures consistent efficacy of each component while simplifying the final formulation process, as the individual extracts are already optimized and ready for combination without requiring complex processing at the final stage.